TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
20 hedge funds and large institutions have $26.2M invested in Trillium Therapeutics Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$358K | |
| 2 | +$254K | |
| 3 | +$240K | |
| 4 |
Millennium Management
New York
|
+$55.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.78K |
Top Sellers
| 1 | -$693K | |
| 2 | -$540K | |
| 3 | -$264K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$131K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$89K |